Advertisement


Drug Controller General Of India Dcgi
Opinion  /  Published 28.07.20

The fact of the matter

We read a recent opinion article titled, “An opaque model of drug approval”, in The Telegraph with interest. We respectfully disagree with the author, and appreciate the opportun...
By Sundar Ramanan in

Business  /  Published 05.03.20

Nod for Zydus liver drug

Zydus Cadila on Thursday said it has received approval from the Drug Controller General of India (DCGI) for its new drug application for Saroglitazar to treat a particular condition of liver, known as...
By Vivek Nair in Ahmedabad

Health  /  Published 10.03.20

Anti-HIV drugs for coronavirus-affected Italians

Amid rising coronavirus cases in India, for the first time a combination of two drugs, which is widely used for controlling HIV infection, was administered on an elderly Italian couple undergoing trea...
By PTI in New Delhi

Opinion  /  Published 28.03.19

A rash approach to clinical drug trials

Haste makes waste. This adage can serve as a timely warning for the Drug Controller General of India which has notified the final rules — a draft version was issued last year — to guide clinical t...
By The Editorial Board in

India  /  Published 18.04.20

DCGI permits clinical trial of convalescent plasma

The central drug regulator has given its go-ahead to a proposal by the Indian Council of Medical Research for the clinical trial of convalescent plasma in COVID-19 patients, as per the protocol develo...
By PTI in New Delhi


Advertisement

Download our latest App

to get update on the go...

Advertisement

Advertisement
 
Copyright © 2020 The Telegraph. All rights reserved.